{
  "docId": "019dd923-622c-750b-8b9a-40e2965928db",
  "docSlug": "e5bffbaac707",
  "documentTitle": "TransMedics (TMDX)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-01-10 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 306,
  "pageCount": 342,
  "prevPage": 305,
  "nextPage": 307,
  "slideType": "testimonial",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a 'villain' narrative structure to frame TransMedics as vulnerable to upcoming competition.",
  "elementsJson": [
    "paragraph",
    "quote_block"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-40e2965928db/306",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-40e2965928db",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-40e2965928db.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-40e2965928db#slide-306",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "the cost is going to go down...you are going to have other competitors...people are going to start shifting gears...to a different pump because it's not sustainable.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-5374-767b-b3bd-77d3734115b0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "paragraph",
      "text": "Surgeons indicate that the new devices are the buzz at transplant conferences, with the field eager to defect to alternatives given widespread alienation with TransMedics business practices – and that the company is basically toast.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2f6fb113-3ee7-4702-b1f3-47d618bc7565",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.86,
        "x": 0.07,
        "y": 0.51
      },
      "kind": "quote",
      "text": "Buzz at transplant conferences about new entrants and competition: 'This was certainly hallway conversations at ATC...'",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "122ed55a-d6c5-4700-900c-c8fcca30f82d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.16,
        "w": 0.86,
        "x": 0.07,
        "y": 0.78
      },
      "kind": "quote",
      "text": "'Guaranteed' FDA approval for new entrants and market shift to different pumps: 'There’s going to be a point where the cost is going to go down...'",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9b7671f5-019c-41ec-90f2-ab9bf7146325",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.86,
        "x": 0.07,
        "y": 0.67
      },
      "kind": "quote",
      "text": "Will be game with if new devices are comparable as so much cheaper: 'If there is not much of an advantage...'",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f6f3c1f3-345d-4cd4-b2b9-fbbb173aceee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"This was certainly hallway conversations at ATC. The discussion that people had in the hallways was, first of all, we’re glad there’s going to be competition, so TransMedics can’t be the only game in town. Almost everybody was saying that. Again, I’ll leave it to you whether this would devastate their earnings reports or not…this is not going to stay exclusive much longer.\" — Cardiothoracic transplant surgeon, director of a leading academic transplant center; \"If there is not much of an advantage of having this incredibly expensive setup versus a $30k different technology, then I think they’re going to have a very hard time selling it.\" — Transplant hepatologist and director of the liver program at a Midwest academic center; \"There’s going to be a point where the cost is going to go down. Right now, TransMedics doesn’t have big competition. The only competition is called OrganOX. That is the same type of machine perfusion. There are other new companies that are going through the FDA to get approved. Those are different types of pump like hyperthermic machine perfusion. So, I can guarantee you that these companies, they are going to get approved by the FDA. I think that in the next year or two years at the most, you are going to have other competitors with TransMedics. Because of the cost, people are going to start shifting gears, and they’re going to be changing to a different pump because it’s not sustainable for a transplant center...\" — Transplant surgeon in a leadership role at Vanderbilt",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-5374-767b-b3bd-78b79cf89082",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.25,
        "x": 0.07,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9cea9460-19aa-4fed-b9e7-b899b162dcd5",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "antagonist-introduction",
      "slug": null,
      "matchId": "68b67f49-86cf-4219-9d85-18a092de6529",
      "evidence": "Frames TransMedics as the 'villain' facing inevitable decline due to market competition.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}